Back to results
US 5,683,997 AGranted
Substituted benzazepinones
AssigneeCiba-Geigy Corporation
InventorsPeter Buhlmayer, Pascal Furet
Life of this patent
Estimating the term…
Abstract
The invention relates to substituted 3-amino-1-arylalkyl-benzazepin-2-ones of the general formula ##STR1## wherein the substituents are defined in the specification; or salts thereof; to processes for the preparation thereof; and to the use thereof as well as to pharmaceutical compositions that comprise compounds of formula (I) or pharmaceutically acceptable salts thereof.
Claims16
A compound of the formula ##STR18## wherein Ar is aryl;
- X is C.sub.1 -C.sub.2 alkylene or a direct bond;
- R.sub.1 is selected from the group consisting of hydrogen;
- lower alkyl;
- aryl-lower alkyl;
- and an acyl selected from the group consisting of lower alkanoyl, aryl-lower alkanoyl and aroyl, each of which is either unsubstituted or independently substituted by 1-3 substituents independently selected from the group consisting of lower alkyl, aryl-lower alkyl, lower alkoxy-lower alkyl, lower alkoxy, lower alkoxy-lower alkoxy, aryl-lower alkoxy, C.sub.3 -C.sub.7 cycloalkyl, C.sub.3 -C.sub.7 cycloalkyl-lower alkyl, nitro, halogen, trifluoromethyl, and amino, where said amino may be unsubstituted, mono- or independently di-substituted by lower alkyl, aryl-lower alkyl or aryl, or disubstituted by lower alkylene or lower alkyleneoxy-lower alkylene;
- R.sub.2 is lower alkyl, hydroxy-lower alkyl, lower alkoxy-lower alkyl, aryl-lower alkoxy-lower alkyl, aryl-lower alkyl or C.sub.3 -C.sub.7 cycloalkyl-lower alkyl;
- R.sub.3 is carboxy;
- 5-tetrazolyl, PO.sub.2 H.sub.2, PO.sub.3 H.sub.2 or SO.sub.3 H.sub.2 ;
- alkoxycarbonyl;
- lower alkoxy-lower alkoxycarbonyl;
- aryl-lower alkoxycarbonyl;
- aryloxycarbonyl;
- carbamoyl;
- carbamoyl that (i) is monosubstituted by hydroxy, lower alkanesulfonyl, halo-lower alkanesulfonyl or by arylsulfonyl, (ii) is monosubstituted or disubstituted, the substituents independently selected from the group consisting of lower alkyl, lower alkenyl, lower alkynyl and phenyl-lower alkyl, or (iii) is disubstituted by lower alkylene or by lower alkylene-X.sub.1 -lower alkylene, wherein X.sub.1 is selected from the group consisting of O, S and NH;
- the ring A is unsubstituted or mono- or poly-substituted by substituents selected from the group consisting of:
- lower alkyl, aryl-lower alkyl, lower alkoxy-lower alkyl, lower alkoxy, lower alkoxy-lower alkoxy, aryl-lower alkoxy, C.sub.3 -C.sub.7 cycloalkyl, C.sub.3 -C.sub.7 cycloalkyl-lower alkyl, nitro, halogen, trifluoromethyl, and amino, where said amino may be unsubstituted, mono- or independently di-substituted by lower alkyl, aryl-lower alkyl or by aryl, or disubstituted by lower alkylene or lower alkyleneoxy-lower alkylene;
- "aryl" in each case above is an independently-selected "carbocyclic or heterocyclic aryl" which may be independently substituted by 1-3 substituents independently selected from the group consisting of lower alkyl, "carbocyclic or heterocyclic aryl"-lower alkyl, lower alkoxy-lower alkyl, lower alkoxy, lower alkoxy-lower alkoxy, "carbocyclic or heterocyclic aryl"-lower alkoxy, C.sub.3 -C.sub.7 cycloalkyl, C.sub.3 -C.sub.7 cycloalkyl-lower alkyl, nitro, halogen, trifluoromethyl, and amino, where said amino may be unsubstituted, mono- or independently di-substituted by lower alkyl, "carbocyclic or heterocyclic aryl"-lower alkyl or "carbocyclic or heterocyclic aryl", or disubstituted by lower alkylene or lower alkyleneoxy-lower alkylene:
- and
- "carbocyclic or heterocyclic aryl" is selected from the group consisting of phenyl, naphthyl, pyrrolyl, pyridyl, furyl, thienyl, imidazolyl, isoxazolyl, and thiazolyl;
- a stereoisomer or a metal, mineral, ammonium, or organic salt thereof.
17 more elements
A compound selected from
- 3-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-isopropyl-benzyl)-2,3,4, 5-tetrahydro-benzazepin-2-one;
- 3-(1-(S)-carboxy-3-phenyl-propyl)-amino!-1-(p-isopropyl-benzyl)-2,3,4,5-te trahydro-benzazepin-2-one;
- 3-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-nitrobenzyl)-2,3,4,5-tet rahydro-benzazepin-2-one;
- 3-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-aminobenzyl)-2,3,4,5-tet rahydro-benzazepin-2-one;
- 3-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-tert-butylbenzyl)-2,3,4, 5-tetrahydro-benzazepin-2-one;
- 3-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-methylbenzyl)-2,3,4,5-te trahydro-benzazepin-2-one;
- 3-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-dimethylaminobenzyl)-2,3 ,4,5-tetrahydro-benzazepin-2-one;
- 3-N-acetyl-N-(1-(S)-carboxy-3-phenyl-propyl)-amino!-1-(p-isopropylbenzyl)- 2,3,4,5-tetrahydro-benzazepin-2-one;
- 3-(1-(S)-carboxy-3-phenyl-propyl)-amino!-1-benzyl-2,3,4,5-tetrahydro-benza zepin-2-one;
- 3-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-benzyl-2,3,4,5-tetrahydro-b enzazepin-2-one;
- 3-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-methoxybenzyl)-2,3,4,5-t etrahydro-benzazepin-2-one;
- and
- 3-(1-(S)-carboxy-2-phenyl-ethyl)-amino!-1-(p-isopropylbenzyl)-2,3,4,5-tetr ahydro-benzazepin-2-one;
- or a salt thereof.
11 more elements
A compound selected from
- 3-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-nitrobenzyl)-2,3,4,5-tet rahydro-benzazepin-2-one;
- 3-(S)-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-aminobenzyl)-2,3,4,5 -tetrahydro-benzazepin-2-one;
- 3-(S)-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-tert-butylbenzyl)-2, 3,4,5-tetrahydro-benzazepin-2-one;
- 3-(R)-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-tert-butylbenzyl)-2, 3,4,5-tetrahydro-benzazepin-2-one;
- 3-(S)-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-methylbenzyl)-2,3,4, 5-tetrahydro-benzazepin-2-one;
- 3-(R)-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-methylbenzyl)-2,3,4, 5-tetrahydro-benzazepin-2-one;
- 3-(S)-(1-(S)-carboxy-2-phenylethyl)-amino!-1-(p-isopropylbenzyl)-2,3,4,5-t etrahydro-benzazepin-2-one;
- 3-(R)-(1-(S)-carboxy-2-phenylethyl)-amino!-1-(p-isopropylbenzyl)-2,3,4,5-t etrahydro-benzazepin-2-one;
- 3-(S)-(1-(S)-carboxy-3-phenylpropyl)-amino!-1-(p-methylbenzyl)-2,3,4,5-tet rahydro-benzazepin-2-one;
- 3-(R)-(1-(S)-carboxy-3-phenylpropyl)-amino!-1-(p-methylbenzyl)-2,3,4,5-tet rahydro-benzazepin-2-one;
- 3-(S)-(1-(S)-N-hydroxy-carbamoyl-3-cyclohexylpropyl)-amino!-1-(p-isopropyl benzyl)-2,3,4,5-tetrahydro-benzazepin-2-one;
- 3-(S)-(1-(S)-carbamoyl-3-cyclohexylpropyl)-amino!-1-(p-isopropylbenzyl)-2, 3,4,5-tetrahydro-benzazepin-2-one;
- 3-(S)-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-dimethylaminobenzyl) -2,3,4,5-tetrahydro-benzazepin-2-one;
- 3-(R)-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-dimethylaminobenzyl) -2,3,4,5-tetrahydro-benzazepin-2-one;
- 3-(S)-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(benzyl)-2,3,4,5-tetrah ydro-benzazepin-2-one;
- 3-(R)-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(benzyl)-2,3,4,5-tetrah ydro-benzazepin-2-one;
- 3-(S)-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-methoxybenzyl)-2,3,4 ,5-tetrahydro-benzazepin-2-one;
- 3-(R)-(1-(S)-carboxy-3-cyclohexyl-propyl)-amino!-1-(p-methoxybenzyl)-2,3,4 ,5-tetrahydro-benzazepin-2-one;
- and
- 3-(S)-(1-(S)-carboxy-3-cyclohexyl-propyl)-N-acetylamino!-1-(p-isopropylben zyl)-2,3,4,5-tetrahydro-benzazepin-2-one;
- or a salt thereof in each case.
18 more elements
A process for the preparation of a compound of formula I, a stereoisomer or a salt thereof, which comprises
- a) in a compound of formula ##STR21## wherein X.sub.1 is a radical that can be converted into the variable R.sub.3, or in a salt thereof, converting X.sub.1 into the variable R.sub.3 ;
- or,
- b) for the preparation of a compound of formula (I) wherein R.sub.1, is hydrogen, or for the preparation of a salt thereof, in a compound of formula ##STR22## wherein X.sub.2 is an amino-protecting group, or in a salt thereof, removing the amino-protecting group;
- or
- c) reacting a compound of formula ##STR23## with a compound of formula ##STR24## wherein X.sub.5 is a nucleofugal leaving group, or with a compound of formula R.sub.2 --CO--R.sub.3 (IVc) or a salt thereof;
- or
- d) reacting a compound of formula ##STR25## with a compound of formula X.sub.6 --X--Ar (Vb), wherein X.sub.6 is a nucleofugal leaving group, or with a salt thereof;
- or
- e) reacting a compound of formula ##STR26## wherein X.sub.7 is (i) oxo or (ii) reactive esterified hydroxy together with hydrogen, with a compound of formula ##STR27## or with a salt thereof;
- and in each case, if desired, converting a compound of formula I obtainable according to the process or in some other manner, in each case in free form or salt form, into a different compound of formula I, separating a mixture of isomers obtainable according to the process and isolating the desired isomer and/or converting a free compound of formula I obtainable according to the process into a salt or a salt of a compound of formula I obtainable according to the process into the free compound of formula I or into a different salt.
7 more elements
Dependencies are inferred from the claim text.